References: Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]

Views

CrossRef citations to date

Altmetric

References

AbeMTsushimaKSakayoriMUtility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective studyDrug Des Devel Ther2018123369337510.2147/DDDT
PubMed Web of Science ®Google Scholar
NakatsukaYHandaTKokosiMThe clinical significance of body weight loss in idiopathic pulmonary fibrosis patientsRespiration20189633834710.1159/00048947430130749
PubMed Web of Science ®Google Scholar
LeyBCollardHRKingTEClinical course and prediction of survival in idiopathic pulmonary fibrosisAm J Respir Crit Care Med201118343144010.1164/rccm.201006-0894CI20935110
PubMed Web of Science ®Google Scholar
WuytsWAKolbMStowasserSStansenWHugginsJTRaghuGFirst data on efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis and forced vital capacity of ≤50% of predicted valueLung201619473974310.1007/s00408-016-9912-127377558
PubMed Web of Science ®Google Scholar
KolbMRaghuGWellsAUNintedanib plus sildenafil in patients with idiopathic pulmonary fibrosisN Engl J Med20183791722173130220235
PubMed Web of Science ®Google Scholar
YoonHYParkSKimDSSongJWEfficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosisRespir Res20181920310.1186/s12931-018-0907-830340638
PubMed Web of Science ®Google Scholar
TzouvelekisAKarampitsakosTKontouMSafety and efficacy of nintedanib in idiopathic pulmonary fibrosis: a real-life observational study in GreecePulm Pharmacol Ther201849616610.1016/j.pupt.2018.01.00629366978
PubMed Web of Science ®Google Scholar